Written question asked by Lord Dodds of Duncairn (Democratic Unionist Party) on Wednesday, 21 April 2021, in the House of Lords. It was due for an answer on Thursday, 6 May 2021. It was answered by Lord Bethell (Conservative) on Thursday, 29 April 2021 on behalf of the Department of Health and Social Care.
NHS: Drugs
- Question
-
To ask Her Majesty's Government what assessment they have made of the availability of new drugs and medicines in Northern Ireland under the separate licensing arrangements established by the Protocol on Ireland/Northern Ireland.
- Answer
-
We are continuing to engage with the European Union on the movement of medicines into Northern Ireland, as part of conversations regarding outstanding issues on the Protocol. Whilst these discussions are ongoing, we have not made a full assessment of the impact of the Protocol. However, we remain committed to maintaining the availability of medicines and drugs in Northern Ireland and actively monitor the situation.
Secondary information
- Type
- Written question
- Reference
- HL15144
- Session
- 2019-21
- Grouped for answer
- Yes
- Subjects
- Licensing Drugs NHS Northern Ireland Northern Ireland Protocol
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-05-06 13:52:49 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/lords/2019-21/HL15144
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/lords/2019-21/HL15144
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/lords/2019-21/HL15144